[HTML][HTML] Prevalence of and risk factors for post-intensive care syndrome: Multicenter study of patients living at home after treatment in 12 Japanese intensive care units …
…, M Kitayama, M Shirasaka, J Haruna, Y Satoi… - PLoS …, 2021 - journals.plos.org
Few studies have examined the epidemiology of post-intensive care syndrome in Japan. This
study investigated the mental health and quality of life of patients living at home in Japan …
study investigated the mental health and quality of life of patients living at home in Japan …
[HTML][HTML] Appetite loss and associated factors at 1 year after intensive care unit elder survivors in a secondary analysis of the SMAP-HoPe study
…, Y Fukuda, T Nagao, M Shirasaka, J Haruna, Y Satoi… - Scientific Reports, 2023 - nature.com
Appetite loss, a common but serious issue in older patients, is an independent risk factor for
sarcopenia, which is associated with high mortality. However, few studies have explored the …
sarcopenia, which is associated with high mortality. However, few studies have explored the …
[HTML][HTML] Employment status and its associated factors for patients 12 months after intensive care: Secondary analysis of the SMAP-HoPe study
…, M Hino, Y Shiba, T Nagao, M Shirasaka, Y Satoi… - Plos one, 2022 - journals.plos.org
Background Returning to work is a serious issue that affects patients who are discharged
from the intensive care unit (ICU). This study aimed to clarify the employment status and the …
from the intensive care unit (ICU). This study aimed to clarify the employment status and the …
The Appetite of Patients 12 Months After Intensive Care Unit Discharge is Associated with Depression
…, Y Fukuda, T Nagao, M Kitayama, M Shirasaka, Y Satoi… - 2022 - preprints.org
Abstract: Appetite loss is common in older patients and an independent risk factor for
sarcopenia, which is associated with high mortality. However, few studies have explored the …
sarcopenia, which is associated with high mortality. However, few studies have explored the …
New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS)
A Oba, M Del Chiaro, S Satoi, SW Kim… - Journal of Hepato …, 2022 - Wiley Online Library
The symposium “New criteria of resectability for pancreatic cancer” was held during the 33nd
meeting of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS) in 2021 …
meeting of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS) in 2021 …
Clinical impact of neoadjuvant chemotherapy and chemoradiotherapy in borderline resectable pancreatic cancer: analysis of 884 patients at facilities specializing in …
…, Y Hosokawa, Y Murakami, H Yamaue, S Satoi… - Annals of surgical …, 2019 - Springer
Background The efficacy of neoadjuvant therapy (NAT), including neoadjuvant chemotherapy
(NAC) and neoadjuvant chemo-radiotherapy (NACRT), for patients with borderline …
(NAC) and neoadjuvant chemo-radiotherapy (NACRT), for patients with borderline …
“Conversion surgery” for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology …
…, I Matsumoto, N Sasahira, Y Nagakawa, S Satoi… - Pancreatology, 2023 - Elsevier
Locally advanced pancreatic cancer (LAPC), which progresses locally and surrounds major
vessels, has historically been deemed unresectable. Surgery alone failed to provide …
vessels, has historically been deemed unresectable. Surgery alone failed to provide …
Ultrasonic scalpel for gastric cancer surgery: a prospective randomized study
…, H Yanagimoto, H Toyokawa, S Satoi… - Journal of …, 2012 - Elsevier
Background The aim of the study was to evaluate the potential advantages of the ultrasonic
scalpel compared with the conventional technique in gastric cancer surgery. Methods …
scalpel compared with the conventional technique in gastric cancer surgery. Methods …
Impact of S‐1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas …
Background Based on the Japan Adjuvant Study Group of Pancreatic Cancer 01 study, the
standard duration of adjuvant chemotherapy with S‐1 (an oral 5‐fluorouracil prodrug …
standard duration of adjuvant chemotherapy with S‐1 (an oral 5‐fluorouracil prodrug …
[HTML][HTML] Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the …
…, H Kitagawa, K Uemura, Y Kimura, S Satoi… - Journal of …, 2023 - Springer
Background Based on the Japan Adjuvant Study Group of Pancreatic Cancer-01 results, S-1
adjuvant chemotherapy has been the standard in resected pancreatic ductal …
adjuvant chemotherapy has been the standard in resected pancreatic ductal …